The performance of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the expiry in key regions has introduced substantial volatility. Investors are now grappling with the impact of lower-cost alt